Yan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yan Chen has a total of 517 co-authors. Here are the top co-authors by number of shared publications:
Yi Pan
CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China
27 shared publicationsZhenzhen Wang
CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
27 shared publicationsXue You
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
17 shared publicationsDaqian Xu
CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
12 shared publicationsLin Wang
China Animal Health and Epidemiology Center, Qingdao, Shangdong, 266032, China
11 shared publicationsYijun Lin
Xiamen Cardiovascular Hospital School of Medicine Xiamen University Xiamen 361016 China
11 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (4) , C921-C931
Physiological functions of MCT1 and MCT4 in intramuscular lactate shuttle, exercise performance, and glucose disposal
The lactate shuttle within skeletal muscle is crucial for muscle functions, especially during exercise. It has long been proposed that two lactate transporters called MCT1 and MCT4 are involved in the lactate shuttle in the skeletal muscles. This study provides direct evidence that these two transporters are involved in maintaining the physiology and exercise performance of the skeletal muscle by utilizing a mouse model with muscle-specific ablation of these two lactate transporters.
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (4) , C921-C931
Open AccessPhysiological functions of MCT1 and MCT4 in intramuscular lactate shuttle, exercise performance, and glucose disposal
The lactate shuttle within skeletal muscle is crucial for muscle functions, especially during exercise. It has long been proposed that two lactate transporters called MCT1 and MCT4 are involved in the lactate shuttle in the skeletal muscles. This study provides direct evidence that these two transporters are involved in maintaining the physiology and exercise performance of the skeletal muscle by utilizing a mouse model with muscle-specific ablation of these two lactate transporters.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Metabolism and Diseases
- Vol. 1 (2)
Inhibition of glycogen synthase 1 ameliorates imiquimod-induced psoriasis by suppressing JAK2-STAT3 signaling
- 1 September 2026
- Published by KEAI Publishing in Metabolism and Diseases
- Vol. 1 (2)
Open AccessInhibition of glycogen synthase 1 ameliorates imiquimod-induced psoriasis by suppressing JAK2-STAT3 signaling
- Open Access
- 22 June 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (6) , 967
Discovery of Macrocyclic Peptide Inhibitors Targeting MYC Oncoprotein via mRNA Display
Background/Objectives: mRNA display technology has emerged as a powerful platform for discovering macrocyclic peptides against intractable proteins. However, direct screening against the “undruggable” transcription factor MYC using this approach remains largely unexplored. In this study, we aimed to integrate tyrosinase-mediated cyclization with mRNA display to identify novel macrocyclic peptide inhibitors targeting MYC. Methods: We performed mRNA display combined with tyrosinase-mediated cyclization to generate macrocyclic peptides targeting MYC. Antiproliferative activity was assessed in MYC-dependent tumor cells using CCK8 assay. C-terminal fusions with a TAT-derived cell-penetrating peptide were generated to enhance cell membrane permeability. Binding affinities were measured by bio-layer interferometry (BLI). MYC transcriptional activity was evaluated by RNA sequencing (RNA-seq) analysis of canonical MYC target genes. Results: The identified macrocyclic peptides exhibited potent antiproliferative activity against MYC-dependent tumor cells, with half-maximal inhibitory concentration (IC50) values in the micromolar range. Fusion with the TAT peptide improved antiproliferative potency, yielding IC50 values of 1–3 μM in MYC-dependent cell lines. BLI assays confirmed dose-dependent binding of the peptides to MYC, with dissociation constants (Kd) in the micromolar range. Furthermore, RNA-seq analysis revealed significant downregulation of canonical MYC target genes upon treatment with the TAT-fusion macrocyclic peptide, indicating specific suppression of MYC transcriptional activity. Conclusions: This work establishes the feasibility of using mRNA display to target the “undruggable” protein MYC and identifies a panel of macrocyclic peptides as promising lead candidates for further optimization toward targeted therapies for MYC-driven cancers.
- 22 June 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (6) , 967
Open AccessDiscovery of Macrocyclic Peptide Inhibitors Targeting MYC Oncoprotein via mRNA Display
Background/Objectives: mRNA display technology has emerged as a powerful platform for discovering macrocyclic peptides against intractable proteins. However, direct screening against the “undruggable” transcription factor MYC using this approach remains largely unexplored. In this study, we aimed to integrate tyrosinase-mediated cyclization with mRNA display to identify novel macrocyclic peptide inhibitors targeting MYC. Methods: We performed mRNA display combined with tyrosinase-mediated cyclization to generate macrocyclic peptides targeting MYC. Antiproliferative activity was assessed in MYC-dependent tumor cells using CCK8 assay. C-terminal fusions with a TAT-derived cell-penetrating peptide were generated to enhance cell membrane permeability. Binding affinities were measured by bio-layer interferometry (BLI). MYC transcriptional activity was evaluated by RNA sequencing (RNA-seq) analysis of canonical MYC target genes. Results: The identified macrocyclic peptides exhibited potent antiproliferative activity against MYC-dependent tumor cells, with half-maximal inhibitory concentration (IC50) values in the micromolar range. Fusion with the TAT peptide improved antiproliferative potency, yielding IC50 values of 1–3 μM in MYC-dependent cell lines. BLI assays confirmed dose-dependent binding of the peptides to MYC, with dissociation constants (Kd) in the micromolar range. Furthermore, RNA-seq analysis revealed significant downregulation of canonical MYC target genes upon treatment with the TAT-fusion macrocyclic peptide, indicating specific suppression of MYC transcriptional activity. Conclusions: This work establishes the feasibility of using mRNA display to target the “undruggable” protein MYC and identifies a panel of macrocyclic peptides as promising lead candidates for further optimization toward targeted therapies for MYC-driven cancers.
- Open Access
- 18 February 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Glycogen synthase 1 promotes breast cancer progression by promoting IκBα ubiquitination and degradation independent of its canonical enzyme function
Breast cancer remains a global health challenge, with triple-negative breast cancer (TNBC) posing a particular therapeutic difficulty. Glycogen synthase 1
- 18 February 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Open AccessGlycogen synthase 1 promotes breast cancer progression by promoting IκBα ubiquitination and degradation independent of its canonical enzyme function
Breast cancer remains a global health challenge, with triple-negative breast cancer (TNBC) posing a particular therapeutic difficulty. Glycogen synthase 1
- Open Access
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Lactate derived from macrophages drives skin dermal fibroblasts phenotypic remodeling via MCT1-primed histone H3 lysine 23 lactylation in hypertrophic scar
Hypertrophic scar (HS) is a fibroproliferative disorder characterized by fibroblast hyperactivation and aberrant extracellular matrix deposition. This study identifies macrophage-derived lactate as a key mediator of fibroblast phenotypic remodeling via monocarboxylate transporter 1 (MCT1)-mediated histone H3 lysine 23 lactylation (H3K23la) in HS. Elevated lactate levels and MCT1 expression were observed in HS tissues, with macrophages in stiff mechanical microenvironments identified as the primary lactate source. Lactate influx through MCT1 upregulated H3K23la, thereby promoting transcriptional activation of profibrotic genes HEY2 and COL11A1. Mechanistically, HEY2 activated YAP1/SMAD2 signaling, while COL11A1 stabilized MCT1 to enhance lactate transport, forming a positive loop that amplified fibrosis. Fibroblast-specific Mct1 deletion or pharmacological inhibition of Mct1 in male mice reduced collagen deposition, accelerated wound healing, and attenuated scar formation. Our findings redefine the macrophage-fibroblast crosstalk in HS and establish the MCT1-H3K23la-HEY2/COL11A1 axis, particularly its self-reinforcing loop, as a novel therapeutic target.
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessLactate derived from macrophages drives skin dermal fibroblasts phenotypic remodeling via MCT1-primed histone H3 lysine 23 lactylation in hypertrophic scar
Hypertrophic scar (HS) is a fibroproliferative disorder characterized by fibroblast hyperactivation and aberrant extracellular matrix deposition. This study identifies macrophage-derived lactate as a key mediator of fibroblast phenotypic remodeling via monocarboxylate transporter 1 (MCT1)-mediated histone H3 lysine 23 lactylation (H3K23la) in HS. Elevated lactate levels and MCT1 expression were observed in HS tissues, with macrophages in stiff mechanical microenvironments identified as the primary lactate source. Lactate influx through MCT1 upregulated H3K23la, thereby promoting transcriptional activation of profibrotic genes HEY2 and COL11A1. Mechanistically, HEY2 activated YAP1/SMAD2 signaling, while COL11A1 stabilized MCT1 to enhance lactate transport, forming a positive loop that amplified fibrosis. Fibroblast-specific Mct1 deletion or pharmacological inhibition of Mct1 in male mice reduced collagen deposition, accelerated wound healing, and attenuated scar formation. Our findings redefine the macrophage-fibroblast crosstalk in HS and establish the MCT1-H3K23la-HEY2/COL11A1 axis, particularly its self-reinforcing loop, as a novel therapeutic target.
- Open Access
- 20 November 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (12) , 116577
Blocking glycogen synthase 1 in white adipose tissue alleviates hypermetabolism following severe burn injury through inhibition of JAK2 by UDPG
- 20 November 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (12) , 116577
Open AccessBlocking glycogen synthase 1 in white adipose tissue alleviates hypermetabolism following severe burn injury through inhibition of JAK2 by UDPG
- Open Access
- 24 September 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Erythrocyte odd-chain fatty acids and the risk of cardiometabolic diseases: a prospective study and updated meta-analysis
Aim: To determine dietary sources of odd-chain fatty acids (OCFAs) in Asians and their associations with cardiometabolic diseases (CMDs) and to compare these associations with other populations. Methods: Erythrocyte fatty acids were profiled in 8,185 subjects (38% men, mean age 58.1 years) participating in the 2nd resurvey of the China Kadoorie Biobank (CKB) in 2013-14 using gas chromatography. Correlations of pentadecanoic (15:0) and heptadecanoic (17:0) acids with dietary factors, assessed via food frequency questionnaires, were examined by Spearman correlations. During about 5-year follow-up, 950 incident CMD were recorded, including 387 ischemic heart disease (IHD), 127 diabetes, and 459 stroke. Cox regression yielded adjusted hazard ratios (HRs) for CMDs associated with levels of 15:0. These results were further meta-analyzed with 33 additional prospective studies, involving 112,193 participants. Results: OCFAs were significantly correlated with intakes of dairy products, wheat and coarse grains, and fish/seafood in the CKB. Both 15:0 and 17:0 were inversely associated with incident IHD, with adjusted HRs of 0.72 (95% CI 0.59-0.89) and 0.69 (0.56-0.86) for top vs. bottom tertile, respectively. Levels of 17:0 were also inversely associated with incident diabetes (0.41 [0.27-0.62]) and total CMDs (0.85 [0.74-0.97]). In the updated meta-analysis, both 15:0 and 17:0 levels showed inverse associations with diabetes, with pooled relative risks of 0.74 (0.68-0.80) and 0.65 (0.61-0.71) per 10th-90th percentile range, respectively. 17:0 was also inversely associated with incident IHD (0.87 [0.77-0.97]). Conclusions: Our findings supported favorable associations between OCFAs and CMDs among populations with varied dietary sources and intake levels, which merits future intervention studies.
- 24 September 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Open AccessErythrocyte odd-chain fatty acids and the risk of cardiometabolic diseases: a prospective study and updated meta-analysis
Aim: To determine dietary sources of odd-chain fatty acids (OCFAs) in Asians and their associations with cardiometabolic diseases (CMDs) and to compare these associations with other populations. Methods: Erythrocyte fatty acids were profiled in 8,185 subjects (38% men, mean age 58.1 years) participating in the 2nd resurvey of the China Kadoorie Biobank (CKB) in 2013-14 using gas chromatography. Correlations of pentadecanoic (15:0) and heptadecanoic (17:0) acids with dietary factors, assessed via food frequency questionnaires, were examined by Spearman correlations. During about 5-year follow-up, 950 incident CMD were recorded, including 387 ischemic heart disease (IHD), 127 diabetes, and 459 stroke. Cox regression yielded adjusted hazard ratios (HRs) for CMDs associated with levels of 15:0. These results were further meta-analyzed with 33 additional prospective studies, involving 112,193 participants. Results: OCFAs were significantly correlated with intakes of dairy products, wheat and coarse grains, and fish/seafood in the CKB. Both 15:0 and 17:0 were inversely associated with incident IHD, with adjusted HRs of 0.72 (95% CI 0.59-0.89) and 0.69 (0.56-0.86) for top vs. bottom tertile, respectively. Levels of 17:0 were also inversely associated with incident diabetes (0.41 [0.27-0.62]) and total CMDs (0.85 [0.74-0.97]). In the updated meta-analysis, both 15:0 and 17:0 levels showed inverse associations with diabetes, with pooled relative risks of 0.74 (0.68-0.80) and 0.65 (0.61-0.71) per 10th-90th percentile range, respectively. 17:0 was also inversely associated with incident IHD (0.87 [0.77-0.97]). Conclusions: Our findings supported favorable associations between OCFAs and CMDs among populations with varied dietary sources and intake levels, which merits future intervention studies.
- Open Access
Identification of Amino Acids That Regulate Angiogenesis and Alter Pathogenesis of a Mouse Model of Choroidal Neovascularization
Background: Metabolic stress from amino acid (AA) insufficiency is increasingly linked to pathological angiogenesis, but specific essential AA (EAA) roles remain undefined. Neovascular age-related macular degeneration (AMD), a major cause of blindness driven by aberrant ocular neovascularization, has limited efficacy with current VEGFA-targeting therapies. We sought to identify specific EAAs that regulate pathological angiogenesis and dissect their mechanisms to propose new therapeutic strategies. Methods: Human retinal microvascular endothelial cells (HRMVECs) were used to identify angiogenesis-regulating amino acids through systematic EAA screening. The molecular mechanism was investigated using shRNA-mediated knockdown of key stress response regulators (HRI, PKR, PERK, GCN2) and ATF4. Angiogenesis was assessed via tubule formation and migration assays. Therapeutic potential was examined in a laser-induced choroidal neovascularization (CNV) mouse model, evaluated by fluorescein angiography and histomorphometry. Results: Deprivation of methionine, lysine, and threonine potently induced capillary-like tube formation (p < 0.01). Mechanistically, restriction of these three EAAs activated HRI and GCN2 kinases, converging on eIF2α phosphorylation to induce ATF4 and its target VEGFA. Dual, but not single, knockdown of HRI and GCN2 abolished eIF2α-ATF4 signaling and angiogenic responses. Restricting these EAAs exacerbated CNV area in mice. Conclusions: Our findings reveal a coordinated HRI/GCN2-ATF4-VEGFA axis linking EAA scarcity to vascular remodeling, establishing proof-of-concept for targeting this pathway in CNV. This work highlights the therapeutic potential of modulating specific AA availability or targeting the HRI/GCN2-ATF4 axis to treat CNV.
Open AccessIdentification of Amino Acids That Regulate Angiogenesis and Alter Pathogenesis of a Mouse Model of Choroidal Neovascularization
Background: Metabolic stress from amino acid (AA) insufficiency is increasingly linked to pathological angiogenesis, but specific essential AA (EAA) roles remain undefined. Neovascular age-related macular degeneration (AMD), a major cause of blindness driven by aberrant ocular neovascularization, has limited efficacy with current VEGFA-targeting therapies. We sought to identify specific EAAs that regulate pathological angiogenesis and dissect their mechanisms to propose new therapeutic strategies. Methods: Human retinal microvascular endothelial cells (HRMVECs) were used to identify angiogenesis-regulating amino acids through systematic EAA screening. The molecular mechanism was investigated using shRNA-mediated knockdown of key stress response regulators (HRI, PKR, PERK, GCN2) and ATF4. Angiogenesis was assessed via tubule formation and migration assays. Therapeutic potential was examined in a laser-induced choroidal neovascularization (CNV) mouse model, evaluated by fluorescein angiography and histomorphometry. Results: Deprivation of methionine, lysine, and threonine potently induced capillary-like tube formation (p < 0.01). Mechanistically, restriction of these three EAAs activated HRI and GCN2 kinases, converging on eIF2α phosphorylation to induce ATF4 and its target VEGFA. Dual, but not single, knockdown of HRI and GCN2 abolished eIF2α-ATF4 signaling and angiogenic responses. Restricting these EAAs exacerbated CNV area in mice. Conclusions: Our findings reveal a coordinated HRI/GCN2-ATF4-VEGFA axis linking EAA scarcity to vascular remodeling, establishing proof-of-concept for targeting this pathway in CNV. This work highlights the therapeutic potential of modulating specific AA availability or targeting the HRI/GCN2-ATF4 axis to treat CNV.
- 1 September 2025
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 329 (3) , E393-E404
Sex-specific difference in intestinal glucose metabolism is associated with sexually dimorphic postprandial lactate shuttle and glucose homeostasis in mice
Sex dimorphic difference in glucose homeostasis has been well recognized; however, how glucose metabolism in the intestine contributes to this phenomenon is poorly known. We discovered that the male mice have an elevated rate of glycolysis in the intestine, whereas the female mice have an increased rate of oxidative phosphorylation, contributing to the sex difference in glucose tolerance. In addition, sex hormones are crucial in mediating such a difference between the two sexes.
- 1 September 2025
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 329 (3) , E393-E404
Sex-specific difference in intestinal glucose metabolism is associated with sexually dimorphic postprandial lactate shuttle and glucose homeostasis in mice
Sex dimorphic difference in glucose homeostasis has been well recognized; however, how glucose metabolism in the intestine contributes to this phenomenon is poorly known. We discovered that the male mice have an elevated rate of glycolysis in the intestine, whereas the female mice have an increased rate of oxidative phosphorylation, contributing to the sex difference in glucose tolerance. In addition, sex hormones are crucial in mediating such a difference between the two sexes.